adesso SE (0N5I)
London Stock Exchange · UK · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 74.10 |
|---|---|
| 52-week range | 47.35 – 97.40 |
| Return, 1 month / 3 months | +33.5% / +31.2% |
| Return, 1 year / 3 years | −21.0% / −11.7% |
| Trend | Uptrend |
| RSI (14) | 73 |
| Volatility (1 year) | 43.9% |
| Worst drawdown (1 year) | -50.0% |
| Average daily value traded | 0.05M EUR |
| Dividend yield | 1.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
adesso SE is a German information technology services company based in Dortmund. It advises and supports organisations on digital projects, offering IT consulting, custom software development and the modernisation of existing systems. Its customers come from sectors such as insurance, banking, healthcare, automotive and the public sector, mainly in German-speaking countries and elsewhere in Europe. The firm also develops and markets its own software products alongside its project work for clients.
The shares are listed on the London Stock Exchange in UK under the code 0N5I, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
adesso SE (0N5I) trades on the London Stock Exchange in UK. It last closed at EUR 74.10 on 27 October 2026.
Its price-based Market X-Ray is 44 out of 100 (a weak price profile), ranking 2,391 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 21.0% and over the last three months it rose 31.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 60 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 22.0% | ||
| From 52-week high | -23.8% | ||
| Momentum | 63 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 31.2% | ||
| 6-month return | 27.4% | ||
| 12-month return, skipping the last month | -40.8% | ||
| Stability (higher is calmer) | 27 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 43.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -50.0% | ||
| Liquidity | 25 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.05M EUR | ||
| Zero-volume days | 1.7% | ||
| Income | 29 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.1% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +6.5% |
|---|---|
| 1 month | +33.5% |
| 3 months | +31.2% |
| 6 months | +27.4% |
| 1 year | −21.0% |
| 3 years | −11.7% |
| 5 years | −56.6% |
Signals
| 50-day / 200-day average | 61.42 / 60.73 |
|---|---|
| Golden / death cross (60 days) | Golden, 1 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.40 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 4 Jun 2026 | EUR 0.7800 |
| 4 Jun 2025 | EUR 0.7500 |
| 5 Jun 2024 | EUR 0.7000 |
| 2 Jun 2023 | EUR 0.6500 |
| 1 Jun 2022 | EUR 0.6000 |
| 28 May 2021 | EUR 0.5200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.